| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 07/22/2009 | EP1890692B1 Formulations of lipoic acid and the benzyl ester of hyaluronic acid in the pharmaceutical and cosmetic fields |
| 07/22/2009 | EP1503988B1 Fredericamycin derivatives |
| 07/22/2009 | EP1492761B1 Amino acids with affinity for the alpha-2-delta-protein |
| 07/22/2009 | EP1392680B1 Selective anthranilamide pyridine amides as inhibitors of vegfr-2 and vegfr-3 |
| 07/22/2009 | CN101486682A N3 alkylated benzimidazole derivatives as MEK inhibitors |
| 07/22/2009 | CN100516037C Nitrooxyderivatives of cyclooxygenase-2 inhibitors |
| 07/22/2009 | CN100516024C Amino-propanol derivatives |
| 07/22/2009 | CN100516018C Double esters |
| 07/22/2009 | CN100515497C Liposomal delivery of vitamin E based compounds |
| 07/22/2009 | CN100515385C Beauty-white frost of peony and preparation method |
| 07/21/2009 | US7563824 Clathrate complexes formed by hyaluronic acid derivatives and use thereof as pharmaceuticals |
| 07/21/2009 | US7563819 Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy |
| 07/21/2009 | US7563790 Pyridazine derivatives |
| 07/21/2009 | US7563765 Histidine-rich glycoprotein |
| 07/21/2009 | US7563593 Harvesting, separating, culturing and exposing tissue to antiproliferative agents, monitoring variation in tissue propagation; immunotherapeutics; wound healing agents |
| 07/21/2009 | CA2406650C Cationic diagnostic, imaging and therapeutic agents associated with activated vascular sites |
| 07/21/2009 | CA2404548C 2-alkylidene-19-nor-vitamin d compounds and their therapeutic uses |
| 07/21/2009 | CA2387486C Use of dipyridamole or mopidamol in the manufacture of a medicament for the treatment and prevention of fibrin-dependent microcirculation disorders |
| 07/21/2009 | CA2379972C Prodrug of an ice inhibitor |
| 07/16/2009 | WO2009089368A1 Wound healing peptides and methods of use thereof |
| 07/16/2009 | WO2009087949A1 Compound having heterocyclic ring, and use thereof |
| 07/16/2009 | WO2009087560A1 Clottable concentrate of platelet growth factors and preparation method thereof |
| 07/16/2009 | WO2009087354A2 Skincare treatment |
| 07/16/2009 | WO2009087238A2 Chemical molecules that inhibit the slicing mechanism for treating diseases resulting from splicing anomalies |
| 07/16/2009 | WO2009087117A1 Use of peptides for promoting wound healing |
| 07/16/2009 | WO2009086934A1 Composition for treating scalp and skin |
| 07/16/2009 | WO2009086695A1 Use of extractive of bcg polysaccharide and nucleic acid for preparing medicine for treating allergic dermatosis, and its injection and preparation method |
| 07/16/2009 | WO2009086694A1 Use of extractive of bcg polysaccharide and nucleic acid for preparing medicine for treating viral skin diseases, and its injection and preparation method |
| 07/16/2009 | WO2009086595A1 Treatment for dermatological conditions |
| 07/16/2009 | WO2009065946A3 Pharmaceutical kit consisting of an oil-in-water emulsion and a solid composition |
| 07/16/2009 | WO2009064023A8 Skin moisturizer, blood circulation promoter, and external preparations for the skin containing the skin moisturizer and the blood circulation promoter |
| 07/16/2009 | WO2009053564A3 Cosmetic use of a lysate of bifidobacterium species for reinforcing the skin barrier function |
| 07/16/2009 | WO2009053439A3 An amorphous form of an anti-inflammatory compound |
| 07/16/2009 | WO2009043856A3 Modulation of tissue fatty acid composition of a host by human gut bacteria |
| 07/16/2009 | WO2009024707A3 Use of radamea montana extract for preparing a cosmetic composition |
| 07/16/2009 | WO2008145855A8 Pharmaceutical and/or cosmetic composition containing a cytochrome c-activating active ingredient |
| 07/16/2009 | WO2008145854A8 Pharmaceutical and/or cosmetic composition containing peptides |
| 07/16/2009 | WO2008145852A8 Pharmaceutical and/or cosmetic composition containing an active ingredient which is antioxidant and which activates cell energy |
| 07/16/2009 | WO2008145851A8 Pharmaceutical and/or cosmetic composition containing peptides |
| 07/16/2009 | WO2008132458A8 Compositions useful in the modulation of immune responses and the treatment or prevention of inflammatory responses and related methods |
| 07/16/2009 | WO2008062110A8 Cosmetic and/or pharmaceutical composition containing at least one peptide as the active ingredient and use of said peptide |
| 07/16/2009 | WO2007113531A8 Topical drug delivery |
| 07/16/2009 | US20090182055 Fungicidal agent containing n-chlorotaurine and use thereof |
| 07/16/2009 | US20090182054 Topical compositions containing solubilized dicarboxylic acids |
| 07/16/2009 | US20090182051 Cosmeceutical formulation containing palm oils |
| 07/16/2009 | US20090182047 Utilization of dialkylfumarates |
| 07/16/2009 | US20090182027 Methods of using [3.2.0] heterocyclic compounds and analogs thereof |
| 07/16/2009 | US20090181990 Stable amorphous form of pemetrexed disodium |
| 07/16/2009 | US20090181985 IMIDAZO[1,2-b]PYRIDAZINE COMPOUND |
| 07/16/2009 | US20090181982 Substituted pyrroline kinase inhibitors |
| 07/16/2009 | US20090181959 HETEROARYL SUBSTITUTED PYRROLO[2,3-b]PYRIDINES AND PYRROLO[2,3-b]PYRIMIDINES AS JANUS KINASE INHIBITORS |
| 07/16/2009 | US20090181908 Methods and compositions for treating keratin hyperproliferative disorders |
| 07/16/2009 | US20090181888 Skin Repair Accelerating Therapeutic Agent Containing Ghrelin and Derivatives Thereof or Substance Acting On GHS-R1a as Active Ingredient |
| 07/16/2009 | US20090181115 Method of Screening for Compounds That Alter Skin and/or Hair Pigmentation |
| 07/16/2009 | US20090181113 Compositions for the reversal of stratum granulosum in keratinization disorders |
| 07/16/2009 | US20090181085 Use of certain dialkyl fumarates for the preparation of pharmaceutical preparations for use in transplantation medicine or for the therapy of autoimmune diseases and said compositions in the form of micro-tablets or pellets; dimethyl fumarate |
| 07/16/2009 | US20090181074 Mucosal Tissue Dressing And Method Of Use |
| 07/16/2009 | US20090181073 Method for treating irritation caused by hair removal |
| 07/16/2009 | US20090181060 Skin-care compositions |
| 07/16/2009 | US20090181029 Methods for treating interleukin-6 related diseases |
| 07/16/2009 | DE10140361B4 Verwendung einer Biguanide enthaltenden Zubereitung zur Hufpflege Containing biguanides using a preparation for hoof care |
| 07/16/2009 | CA2711652A1 Chemical molecules that inhibit the slicing mechanism for treating diseases resulting from splicing anomalies |
| 07/16/2009 | CA2711502A1 Clottable concentrate of platelet growth factors and preparation method thereof |
| 07/16/2009 | CA2711217A1 Antimicrobial compositions |
| 07/16/2009 | CA2711133A1 Wound healing peptides and methods of use thereof |
| 07/16/2009 | CA2710822A1 Use of peptides for promoting wound healing |
| 07/15/2009 | EP2077849A1 Use of compounds of the avermectin family for the treatment of dermatological disorders in human beings |
| 07/15/2009 | EP2077848A1 Use of compounds of the avermectin family for the treatment of dermatological disorders |
| 07/15/2009 | EP2077833A1 Use of compounds of the milbemycin family for the treatment of dermatological disorders in human beings |
| 07/15/2009 | EP2077832A1 Use of compounds of the avermectin family for the treatment of dermatological disorders in human beings |
| 07/15/2009 | EP2077831A2 Use of 6'-ethyl-lepimectine, 6'-methyl-lepimectine or derivatives thereof for the treatment of dermatological disorders in human beings |
| 07/15/2009 | EP1871738B1 N-alkylcarbonyl-amino acid ester and n-alkylcarbonyl-amino lactone compounds and their use |
| 07/15/2009 | EP1328263B1 Process of making and method of use of tetrahydrocurcuminoids to regulate physiological and pathological events in the skin and mucosa cells |
| 07/15/2009 | EP1268802B1 Beta-like glycoprotein hormone polypeptide and heterodimer |
| 07/15/2009 | EP1141015B1 Insulin-like growth factor (igf) i mutant variants |
| 07/15/2009 | CN101481359A Cyclic protein tyrosine kinase inhibitors |
| 07/15/2009 | CN100513406C Novel quinuclidine derivatives and their use |
| 07/15/2009 | CN100513392C Novel heteroaryl-substituted acetone derivatives as inhibitors of phospholipase A2 |
| 07/15/2009 | CN100513386C Amide for inhibition of IL-8-induced chemiotaxis of neutrophil leucocytes |
| 07/15/2009 | CN100512809C Compounds and methods of treating transplant rejection |
| 07/15/2009 | CN100512646C Deep penetrating anti-microbial compositions |
| 07/15/2009 | CA2613026A1 Added new stem cells processes/methods/techniques |
| 07/14/2009 | US7560569 (2S,4S)-1-[[(4-carbamoylbicyclo[2.2.2]oct-1-yl)amino]acetyl]-4-fluoropyrrolidine-2-carbonitrile, for treating type II diabetes; increase glucagon-like peptide activity |
| 07/14/2009 | US7560558 quinoline pyridyl derivatives antagonist; antitumor agents; renal disease, hepatic fibrosis, cirrhosis, fibroid lung, scleroderma, wound healing, arthritis, congestive cardiac disease, ulcer, ocular disorder, cornea disorder, diabetic nephropathy |
| 07/14/2009 | US7560548 antiinflammatory agent N-{[(2S)-4-(3,4-dichlorobenzyl)morpholin-2-yl]methyl}cyclopropane carboxamide; bronchitis, asthma, chronic obstructive pulmonary disease and rhinitis |
| 07/14/2009 | US7560493 Cosmetic and/or dermatological composition containing at least one oxidation-sensitive hydrophilic active principle and at least one N-vinylimidazole polymer or copolymer |
| 07/14/2009 | US7560486 An isotonic lipid emulsion free of vegetable oils:(i) 78 to 95% by weight of medium chain triglycerides (MCT), (ii) 5 to 22% by weight of fish oil; to increase the amount of omega-3 fatty acids of cell membranes of organs and tissues |
| 07/14/2009 | US7560473 Amine derivative with potassium channel regulatory function, its preparation and use |
| 07/14/2009 | US7560471 5-{4-[1-(2-Ethoxyethyl)-1H-indol-3-yl]piperidin-1-ylmethyl}-2-methoxybenzoic acid; histamine H1 antagonists; bronchial dialtors; asthma; allergic rhinitis; conjunctivitis; dermatitis; urticaria; selective antiallergic effects so less side effect reduction and lower dosage |
| 07/14/2009 | US7560440 Endothelial growth factors; antiischemic agents; neovascularization |
| 07/14/2009 | US7560247 Nucleic acids encoding anti-IL-12 antibodies, and methods of production |
| 07/14/2009 | US7560106 cleaving a heparin-like glycosaminoglycan using modified heparinases having altered binding specificity and activity; angiogenesis inhibition |
| 07/14/2009 | CA2382302C A nucleic acid and encoding polypeptide for use in inhibiting tumor angiogenesis |
| 07/09/2009 | WO2009086440A1 2-methylene-20-methyl-19,24,25,26,27-pentanor-vitamin d analogs |
| 07/09/2009 | WO2009086439A2 2-methylene-(20s,25s)-19,26-dinor-vitamin d analogs |
| 07/09/2009 | WO2009086437A1 (20r)-23,23-difluoro-2-methylene-19-nor-bishomopregnacalciferol-vitamin d analogs |
| 07/09/2009 | WO2009086436A1 (20s)-23,23-difluoro-2-methylene-19-nor-bishomopregnacalciferol-vitamin d analogs |
| 07/09/2009 | WO2009085651A1 Metal carbonate particles for use in medicine and methods of making thereof |
| 07/09/2009 | WO2009085302A2 Method and multilayered device for controlled topical delivery of therapeutic agents to the skin |
| 07/09/2009 | WO2009085177A1 Phenyl acetic acid derivatives as inflammation modulators |